Wall Street Experts
ver. ZuMIgo(08/25)
Revance Therapeutics, Inc.
Rekomendacje
Rekomendacje w naszym serwisie opierają się na ekspertyzach analityków finansowych oraz zbiorczych raportach z różnych źródeł. Źródła tych raportów to zazwyczaj banki inwestycyjne i firmy doradcze, które regularnie publikują swoje oceny rynkowe. Informacje te pozyskujemy z publicznych raportów analitycznych, bezpośrednich zgłoszeń oraz dzięki współpracy z dostawcami danych finansowych i serwisami informacyjnymi.
| Data |
Cena docelowa |
Cena w dniu publikacji |
Firma wydająca rekomendację |
Analityk |
| 2024-09-17 |
7 |
5.955 |
Mizuho Securities |
Vamil Divan |
| 2024-05-10 |
11 |
3.735 |
Piper Sandler |
David Amsellem |
| 2024-05-10 |
11 |
4.29 |
H.C. Wainwright |
Douglas Tsao |
| 2024-05-10 |
8 |
3.7301 |
Mizuho Securities |
Vamil Divan |
| 2023-09-20 |
35 |
13.48 |
Needham |
Serge Belanger |
| 2023-01-10 |
38 |
30.42 |
Needham |
None |
| 2022-11-16 |
37 |
23.76 |
Barclays |
None |
| 2022-08-25 |
24 |
21.26 |
Wells Fargo |
Jacob Hughes |
An error occurred: DataFrame is empty. Check the ticker or date range.
| Dynamika |
1 rok |
3 lata |
5 lat |
10 lat |
| Przychód |
77.0% |
1427.0% |
6176.0% |
37832.0% |
| EBIT |
|
|
|
|
| EPS |
|
|
|
|
| Data |
Sprzedaj |
Trzymaj |
Kupuj |
Liczba rekomendacji |
| 2025-02 |
0% |
87% |
12% |
8 |
| 2025-01 |
0% |
87% |
12% |
8 |
| 2024-12 |
0% |
88% |
11% |
9 |
| 2024-11 |
0% |
53% |
46% |
15 |
| 2024-10 |
0% |
56% |
43% |
16 |
| 2024-09 |
0% |
56% |
43% |
16 |
| 2024-08 |
0% |
50% |
50% |
18 |
| 2024-07 |
0% |
33% |
66% |
12 |
| 2024-06 |
0% |
33% |
66% |
12 |
| 2024-05 |
0% |
0% |
100% |
6 |
| 2024-04 |
0% |
0% |
100% |
6 |
| 2024-03 |
0% |
0% |
100% |
6 |
| 2024-02 |
0% |
0% |
100% |
6 |
| 2024-01 |
0% |
0% |
100% |
6 |
| 2023-12 |
0% |
0% |
100% |
6 |
| 2023-11 |
0% |
0% |
100% |
6 |
| 2023-10 |
0% |
0% |
100% |
6 |
| 2023-09 |
0% |
0% |
100% |
6 |
| 2023-08 |
0% |
0% |
100% |
6 |
| 2023-07 |
0% |
0% |
100% |
6 |
| 2023-06 |
0% |
0% |
100% |
6 |
| 2023-05 |
0% |
0% |
100% |
6 |
| 2023-04 |
0% |
0% |
100% |
6 |
| 2023-03 |
0% |
0% |
100% |
6 |
| 2023-02 |
0% |
0% |
100% |
6 |
| 2023-01 |
0% |
0% |
100% |
7 |
| 2022-12 |
0% |
0% |
100% |
7 |
| 2022-11 |
0% |
0% |
100% |
7 |
| 2022-10 |
0% |
10% |
90% |
10 |
| 2022-09 |
0% |
10% |
90% |
10 |
| 2022-08 |
0% |
0% |
100% |
7 |
| 2022-07 |
0% |
10% |
90% |
10 |
| 2022-06 |
0% |
0% |
100% |
7 |
| 2022-05 |
0% |
10% |
90% |
10 |
| 2022-04 |
0% |
0% |
100% |
7 |
| 2022-03 |
0% |
0% |
100% |
7 |
| 2022-02 |
0% |
0% |
100% |
7 |
| 2022-01 |
0% |
0% |
100% |
7 |
| 2021-12 |
0% |
0% |
100% |
7 |
| 2021-11 |
0% |
0% |
100% |
7 |
| 2021-10 |
0% |
0% |
100% |
7 |
| 2021-09 |
0% |
0% |
100% |
7 |
| 2021-08 |
0% |
0% |
100% |
7 |
| 2021-07 |
0% |
0% |
100% |
7 |
| 2021-06 |
0% |
0% |
100% |
7 |
| 2021-05 |
0% |
0% |
100% |
7 |
| 2021-04 |
0% |
0% |
100% |
7 |
| 2021-03 |
0% |
0% |
100% |
7 |
| 2021-02 |
0% |
9% |
90% |
11 |
| 2021-01 |
0% |
9% |
90% |
11 |
| 2020-12 |
0% |
0% |
100% |
6 |
| 2020-07 |
0% |
7% |
92% |
13 |
| 2020-06 |
0% |
11% |
88% |
18 |
| 2020-05 |
0% |
11% |
88% |
18 |
| 2020-04 |
0% |
8% |
91% |
12 |
| 2020-03 |
0% |
8% |
91% |
12 |
| 2020-02 |
0% |
8% |
91% |
12 |
| 2020-01 |
0% |
8% |
91% |
12 |
| 2019-12 |
0% |
8% |
91% |
12 |
| 2019-11 |
0% |
8% |
91% |
12 |
| 2019-10 |
0% |
8% |
91% |
12 |
| 2019-09 |
0% |
8% |
91% |
12 |
| 2019-08 |
0% |
8% |
91% |
12 |
| 2019-07 |
0% |
8% |
91% |
12 |
| 2019-06 |
0% |
8% |
91% |
12 |
| 2019-05 |
0% |
8% |
91% |
12 |
| 2019-04 |
0% |
8% |
91% |
12 |
| 2019-03 |
0% |
8% |
91% |
12 |
| 2019-02 |
0% |
8% |
91% |
12 |
| 2019-01 |
0% |
8% |
91% |
12 |